Log in  First Connection?

DialysisArchives

Exploring the relationship between intravenous iron therapy and troponin T levels in hemodialysis patients: a cross-sectional study
Dialysis
 5 min.

 Published on 10/09/2025 |  Original article (Full-text)  | Hunjul Marah et al. | BMC Nephrology 2025; 26(1): 510

The prevalence of End-stage renal disease (ESRD) is increasing rapidly worldwide [1]. Patients with ESRD are dependent on peritoneal dialysis or hemodialysis (HD) to get rid of body wastes [2]. The leading cause of death in ESRD patients is cardiovascular disease, which is the most common complication...

Sugar-free chewing gum’s effect on patients receiving maintenance hemodialysis: a meta-analysis of RCTs
Dialysis
 6 min.

 Published on 03/09/2025 |  Original article (Full-text)  | Li Shi-Ying et al. | BMC Nephrology 2025; 26(1): 502

Maintenance hemodialysis (MHD) is an established therapy for end-stage renal disease (ESRD), significantly improving patient survival [1]. However, MHD is frequently complicated by adverse effects, notably thirst—a prevalent and burdensome symptom affecting 32–81% of patients [2]. Crucially,...

Biocompatibility in hemodialysis: artificial membrane and human blood interactions
Dialysis
 17 min.

 Published on 27/08/2025 |  Original article (Full-text)  | Ávila Eduardo et al. | BMC Nephrology 2025; 26(1): 482

Chronic kidney disease (CKD) stage 5 is an increasing global health concern, affecting 3.4 million individuals worldwide [1]. Kidney transplantation is widely regarded as the preferred treatment option among renal replacement therapies (RRTs); however, its availability is limited [2]. As a consequence,...

The efficacy of different types of intradialytic exercise for patients undergoing hemodialysis: a systematic review and network meta-analysis of randomized controlled trials
Dialysis
 4 min.

 Published on 20/08/2025 |  Original article (Full-text)  | Jiang HaiQiang et al. | BMC Nephrology 2025; 26(1): 450

Chronic kidney disease (CKD), commonly resulting from hypertension, diabetes, or glomerular diseases [1], affects approximately 85 million people globally and represents a significant public health concern [2]. As CKD progresses to end-stage renal disease, renal replacement therapies become necessary,...